Table of Content

1 Market Overview of Specialty Generics
1.1 Specialty Generics Market Overview
1.1.1 Specialty Generics Product Scope
1.1.2 Specialty Generics Market Status and Outlook
1.2 Global Specialty Generics Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Specialty Generics Market Size by Region (2024-2034)
1.4 Global Specialty Generics Historic Market Size by Region (2024-2024)
1.5 Global Specialty Generics Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Specialty Generics Market Size (2024-2034)
1.6.1 North America Specialty Generics Market Size (2024-2034)
1.6.2 Europe Specialty Generics Market Size (2024-2034)
1.6.3 Asia-Pacific Specialty Generics Market Size (2024-2034)
1.6.4 Latin America Specialty Generics Market Size (2024-2034)
1.6.5 Middle East & Africa Specialty Generics Market Size (2024-2034)
2 Specialty Generics Market by Type
2.1 Introduction
2.1.1 Injectables
2.1.2 Oral
2.1.3 Others
2.2 Global Specialty Generics Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Specialty Generics Historic Market Size by Type (2024-2024)
2.2.2 Global Specialty Generics Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Specialty Generics Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Specialty Generics Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Specialty Generics Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Specialty Generics Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Specialty Generics Revenue Breakdown by Type (2024-2034)
3 Specialty Generics Market Overview by Application
3.1 Introduction
3.1.1 Retail Pharmacies
3.1.2 Specialty Pharmacies
3.1.3 Hospital Pharmacies
3.2 Global Specialty Generics Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Specialty Generics Historic Market Size by Application (2024-2024)
3.2.2 Global Specialty Generics Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Specialty Generics Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Specialty Generics Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Specialty Generics Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Specialty Generics Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Specialty Generics Revenue Breakdown by Application (2024-2034)
4 Specialty Generics Competition Analysis by Players
4.1 Global Specialty Generics Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Specialty Generics as of 2022)
4.3 Date of Key Players Enter into Specialty Generics Market
4.4 Global Top Players Specialty Generics Headquarters and Area Served
4.5 Key Players Specialty Generics Product Solution and Service
4.6 Competitive Status
4.6.1 Specialty Generics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Teva Pharmaceuticals Industries
5.1.1 Teva Pharmaceuticals Industries Profile
5.1.2 Teva Pharmaceuticals Industries Main Business
5.1.3 Teva Pharmaceuticals Industries Specialty Generics Products, Services and Solutions
5.1.4 Teva Pharmaceuticals Industries Specialty Generics Revenue (US$ Million) & (2024-2024)
5.1.5 Teva Pharmaceuticals Industries Recent Developments
5.2 Akorn, Inc.
5.2.1 Akorn, Inc. Profile
5.2.2 Akorn, Inc. Main Business
5.2.3 Akorn, Inc. Specialty Generics Products, Services and Solutions
5.2.4 Akorn, Inc. Specialty Generics Revenue (US$ Million) & (2024-2024)
5.2.5 Akorn, Inc. Recent Developments
5.3 Mylan N.V.
5.3.1 Mylan N.V. Profile
5.3.2 Mylan N.V. Main Business
5.3.3 Mylan N.V. Specialty Generics Products, Services and Solutions
5.3.4 Mylan N.V. Specialty Generics Revenue (US$ Million) & (2024-2024)
5.3.5 Mallinckrodt Recent Developments
5.4 Mallinckrodt
5.4.1 Mallinckrodt Profile
5.4.2 Mallinckrodt Main Business
5.4.3 Mallinckrodt Specialty Generics Products, Services and Solutions
5.4.4 Mallinckrodt Specialty Generics Revenue (US$ Million) & (2024-2024)
5.4.5 Mallinckrodt Recent Developments
5.5 Sandoz International GmbH
5.5.1 Sandoz International GmbH Profile
5.5.2 Sandoz International GmbH Main Business
5.5.3 Sandoz International GmbH Specialty Generics Products, Services and Solutions
5.5.4 Sandoz International GmbH Specialty Generics Revenue (US$ Million) & (2024-2024)
5.5.5 Sandoz International GmbH Recent Developments
5.6 Pfizer, Inc.
5.6.1 Pfizer, Inc. Profile
5.6.2 Pfizer, Inc. Main Business
5.6.3 Pfizer, Inc. Specialty Generics Products, Services and Solutions
5.6.4 Pfizer, Inc. Specialty Generics Revenue (US$ Million) & (2024-2024)
5.6.5 Pfizer, Inc. Recent Developments
5.7 Sun Pharmaceutical Industries Ltd.
5.7.1 Sun Pharmaceutical Industries Ltd. Profile
5.7.2 Sun Pharmaceutical Industries Ltd. Main Business
5.7.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Products, Services and Solutions
5.7.4 Sun Pharmaceutical Industries Ltd. Specialty Generics Revenue (US$ Million) & (2024-2024)
5.7.5 Sun Pharmaceutical Industries Ltd. Recent Developments
5.8 Valeant Pharmaceuticals
5.8.1 Valeant Pharmaceuticals Profile
5.8.2 Valeant Pharmaceuticals Main Business
5.8.3 Valeant Pharmaceuticals Specialty Generics Products, Services and Solutions
5.8.4 Valeant Pharmaceuticals Specialty Generics Revenue (US$ Million) & (2024-2024)
5.8.5 Valeant Pharmaceuticals Recent Developments
5.9 Apotex Corp.
5.9.1 Apotex Corp. Profile
5.9.2 Apotex Corp. Main Business
5.9.3 Apotex Corp. Specialty Generics Products, Services and Solutions
5.9.4 Apotex Corp. Specialty Generics Revenue (US$ Million) & (2024-2024)
5.9.5 Apotex Corp. Recent Developments
5.10 Endo International plc.
5.10.1 Endo International plc. Profile
5.10.2 Endo International plc. Main Business
5.10.3 Endo International plc. Specialty Generics Products, Services and Solutions
5.10.4 Endo International plc. Specialty Generics Revenue (US$ Million) & (2024-2024)
5.10.5 Endo International plc. Recent Developments
6 North America
6.1 North America Specialty Generics Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Specialty Generics Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Specialty Generics Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Specialty Generics Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Specialty Generics Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Specialty Generics Market Dynamics
11.1 Specialty Generics Industry Trends
11.2 Specialty Generics Market Drivers
11.3 Specialty Generics Market Challenges
11.4 Specialty Generics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Specialty Generics Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Specialty Generics Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Specialty Generics Market Size Share by Region (2024-2024)
Table 4. Global Specialty Generics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Specialty Generics Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Specialty Generics Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Specialty Generics Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Specialty Generics Revenue Market Share by Type (2024-2024)
Table 9. Global Specialty Generics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Specialty Generics Revenue Market Share by Type (2024-2034)
Table 11. North America Specialty Generics Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Specialty Generics Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Specialty Generics Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Specialty Generics Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Specialty Generics Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Specialty Generics Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Specialty Generics Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Specialty Generics Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Specialty Generics Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Specialty Generics Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Specialty Generics Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Specialty Generics Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Specialty Generics Revenue Market Share by Application (2024-2024)
Table 24. Global Specialty Generics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Specialty Generics Revenue Market Share by Application (2024-2034)
Table 26. North America Specialty Generics Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Specialty Generics Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Specialty Generics Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Specialty Generics Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Specialty Generics Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Specialty Generics Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Specialty Generics Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Specialty Generics Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Specialty Generics Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Specialty Generics Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Specialty Generics Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Specialty Generics Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Specialty Generics as of 2022)
Table 39. Date of Key Players Enter into Specialty Generics Market
Table 40. Global Specialty Generics Key Players Headquarters and Area Served
Table 41. Specialty Generics Product Solution and Service
Table 42. Global Specialty Generics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Teva Pharmaceuticals Industries Basic Information List
Table 45. Teva Pharmaceuticals Industries Description and Business Overview
Table 46. Teva Pharmaceuticals Industries Specialty Generics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Specialty Generics Business of Teva Pharmaceuticals Industries (2024-2024)
Table 48. Teva Pharmaceuticals Industries Recent Developments
Table 49. Akorn, Inc. Basic Information List
Table 50. Akorn, Inc. Description and Business Overview
Table 51. Akorn, Inc. Specialty Generics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Specialty Generics Business of Akorn, Inc. (2024-2024)
Table 53. Akorn, Inc. Recent Developments
Table 54. Mylan N.V. Basic Information List
Table 55. Mylan N.V. Description and Business Overview
Table 56. Mylan N.V. Specialty Generics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Specialty Generics Business of Mylan N.V. (2024-2024)
Table 58. Mylan N.V. Recent Developments
Table 59. Mallinckrodt Basic Information List
Table 60. Mallinckrodt Description and Business Overview
Table 61. Mallinckrodt Specialty Generics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Specialty Generics Business of Mallinckrodt (2024-2024)
Table 63. Mallinckrodt Recent Developments
Table 64. Sandoz International GmbH Basic Information List
Table 65. Sandoz International GmbH Description and Business Overview
Table 66. Sandoz International GmbH Specialty Generics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Specialty Generics Business of Sandoz International GmbH (2024-2024)
Table 68. Sandoz International GmbH Recent Developments
Table 69. Pfizer, Inc. Basic Information List
Table 70. Pfizer, Inc. Description and Business Overview
Table 71. Pfizer, Inc. Specialty Generics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Specialty Generics Business of Pfizer, Inc. (2024-2024)
Table 73. Pfizer, Inc. Recent Developments
Table 74. Sun Pharmaceutical Industries Ltd. Basic Information List
Table 75. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 76. Sun Pharmaceutical Industries Ltd. Specialty Generics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Specialty Generics Business of Sun Pharmaceutical Industries Ltd. (2024-2024)
Table 78. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 79. Valeant Pharmaceuticals Basic Information List
Table 80. Valeant Pharmaceuticals Description and Business Overview
Table 81. Valeant Pharmaceuticals Specialty Generics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Specialty Generics Business of Valeant Pharmaceuticals (2024-2024)
Table 83. Valeant Pharmaceuticals Recent Developments
Table 84. Apotex Corp. Basic Information List
Table 85. Apotex Corp. Description and Business Overview
Table 86. Apotex Corp. Specialty Generics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Specialty Generics Business of Apotex Corp. (2024-2024)
Table 88. Apotex Corp. Recent Developments
Table 89. Endo International plc. Basic Information List
Table 90. Endo International plc. Description and Business Overview
Table 91. Endo International plc. Specialty Generics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Specialty Generics Business of Endo International plc. (2024-2024)
Table 93. Endo International plc. Recent Developments
Table 94. North America Specialty Generics Market Size by Country (2024-2024) & (US$ Million)
Table 95. North America Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 96. Europe Specialty Generics Market Size by Country (2024-2024) & (US$ Million)
Table 97. Europe Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Specialty Generics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Asia-Pacific Specialty Generics Market Size by Region (2024-2024) & (US$ Million)
Table 100. Asia-Pacific Specialty Generics Market Size by Region (2024-2034) & (US$ Million)
Table 101. Asia-Pacific Specialty Generics Market Share by Region (2024-2024)
Table 102. Asia-Pacific Specialty Generics Market Share by Region (2024-2034)
Table 103. Latin America Specialty Generics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Latin America Specialty Generics Market Size by Country (2024-2024) & (US$ Million)
Table 105. Latin America Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 106. Middle East & Africa Specialty Generics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 107. Middle East & Africa Specialty Generics Market Size by Country (2024-2024) & (US$ Million)
Table 108. Middle East & Africa Specialty Generics Market Size by Country (2024-2034) & (US$ Million)
Table 109. Specialty Generics Market Trends
Table 110. Specialty Generics Market Drivers
Table 111. Specialty Generics Market Challenges
Table 112. Specialty Generics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Generics Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Specialty Generics Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Specialty Generics Market Share by Regions: 2022 VS 2034
Figure 4. Global Specialty Generics Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Specialty Generics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Specialty Generics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Specialty Generics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Specialty Generics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Specialty Generics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Injectables
Figure 11. Global Injectables Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Oral
Figure 13. Global Oral Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Specialty Generics Market Size Share by Type: 2022 & 2034
Figure 17. North America Specialty Generics Revenue Market Share by Type (2024-2034)
Figure 18. Europe Specialty Generics Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Specialty Generics Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Specialty Generics Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Specialty Generics Revenue Market Share by Type (2024-2034)
Figure 22. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Specialty Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Specialty Generics Market Size Share by Application: 2022 & 2034
Figure 26. North America Specialty Generics Revenue Market Share by Application (2024-2034)
Figure 27. Europe Specialty Generics Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Specialty Generics Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Specialty Generics Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Specialty Generics Revenue Market Share by Application (2024-2034)
Figure 31. Specialty Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Specialty Generics Market Share in 2022
Figure 33. North America Specialty Generics Market Share by Country (2024-2034)
Figure 34. U.S. Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 37. France Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Specialty Generics Market Share by Region (2024-2034)
Figure 43. China Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 47. India Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Specialty Generics Market Share by Country (2024-2034)
Figure 50. Mexico Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Specialty Generics Market Share by Country (2024-2034)
Figure 53. Turkey Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Specialty Generics Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report